Back to Search
Start Over
Radiotherapy for anti-vascular endothelial growth factor injections for neovascular age-related macular degeneration.
- Source :
-
Lancet (London, England) [Lancet] 2024 Jul 06; Vol. 404 (10447), pp. 4-5. Date of Electronic Publication: 2024 Jun 11. - Publication Year :
- 2024
-
Abstract
- Competing Interests: GSY is currently funded by grants from the National Eye Institute of the National Institute of Health. He has received biostatistics consultation fees from Ziemmer Ophthalmic Systems and has received fees for services as a member of the data safety monitoring committee for Advarra. BLVB has received an honorarium for being an organiser and presenter at the 2023 Real World Data Symposium.
- Subjects :
- Humans
Intravitreal Injections
Ranibizumab administration & dosage
Ranibizumab therapeutic use
Wet Macular Degeneration drug therapy
Antibodies, Monoclonal, Humanized therapeutic use
Antibodies, Monoclonal, Humanized administration & dosage
Vascular Endothelial Growth Factor A antagonists & inhibitors
Angiogenesis Inhibitors administration & dosage
Angiogenesis Inhibitors therapeutic use
Macular Degeneration drug therapy
Macular Degeneration radiotherapy
Subjects
Details
- Language :
- English
- ISSN :
- 1474-547X
- Volume :
- 404
- Issue :
- 10447
- Database :
- MEDLINE
- Journal :
- Lancet (London, England)
- Publication Type :
- Academic Journal
- Accession number :
- 38876134
- Full Text :
- https://doi.org/10.1016/S0140-6736(24)00915-2